82 related articles for article (PubMed ID: 20460760)
1. Shikonin induces apoptosis through reactive oxygen species/extracellular signal-regulated kinase pathway in osteosarcoma cells.
Chang IC; Huang YJ; Chiang TI; Yeh CW; Hsu LS
Biol Pharm Bull; 2010; 33(5):816-24. PubMed ID: 20460760
[TBL] [Abstract][Full Text] [Related]
2. Shikonin Protects PC12 Cells Against β-amyloid Peptide-Induced Cell Injury Through Antioxidant and Antiapoptotic Activities.
Tong Y; Bai L; Gong R; Chuan J; Duan X; Zhu Y
Sci Rep; 2018 Jan; 8(1):26. PubMed ID: 29311595
[TBL] [Abstract][Full Text] [Related]
3. The Biological Assessment of Shikonin and β,β-dimethylacrylshikonin Using a Cellular Myxofibrosarcoma Tumor Heterogeneity Model.
Lohberger B; Kaltenegger H; Eck N; Glänzer D; Leithner A; Kretschmer N
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958891
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Effects of Shikonin and Its Potential in Skin Repair: A Review.
Song Y; Ding Q; Hao Y; Cui B; Ding C; Gao F
Molecules; 2023 Dec; 28(24):. PubMed ID: 38138440
[TBL] [Abstract][Full Text] [Related]
5. Shikonin Induces Apoptosis, Necrosis, and Premature Senescence of Human A549 Lung Cancer Cells through Upregulation of p53 Expression.
Yeh YC; Liu TJ; Lai HC
Evid Based Complement Alternat Med; 2015; 2015():620383. PubMed ID: 25737737
[TBL] [Abstract][Full Text] [Related]
6. Research Progress of the Molecular Mechanism of Antithyroid Cancer Activity of Shikonin.
Sun C; Liao L
Curr Mol Pharmacol; 2024; 17():e040923220678. PubMed ID: 37670707
[TBL] [Abstract][Full Text] [Related]
7. Retraction Note: Experimental evidence of shikonin as a novel intervention for anti-inflammatory effects.
Chen X; Lin S; Liang Y; Xue X; Yasen M
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; ():. PubMed ID: 38748231
[No Abstract] [Full Text] [Related]
8. Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2.
Chen J; Xie J; Jiang Z; Wang B; Wang Y; Hu X
Oncogene; 2011 Oct; 30(42):4297-306. PubMed ID: 21516121
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic effect and cell arrest of deoxyshikonin in human osteosarcoma cells through the p38 pathway.
Hsieh MC; Hsieh YH; Chou CH; Yang JS; Lu PW; Huang TY; Yang SF; Lu KH
J Cell Mol Med; 2023 Jun; 27(11):1592-1602. PubMed ID: 37155410
[TBL] [Abstract][Full Text] [Related]
10. Improving Properties of Podophyllic Aldehyde-Derived Cyclolignans: Design, Synthesis and Evaluation of Novel Lignohydroquinones, Dual-Selective Hybrids against Colorectal Cancer Cells.
Hernández ÁP; Díez P; García PA; Pérez-Andrés M; Veselinova A; Jambrina PG; San Feliciano A; Díez D; Fuentes M; Castro MÁ
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986749
[TBL] [Abstract][Full Text] [Related]
11. Traditional Medicinal Plants as a Source of Inspiration for Osteosarcoma Therapy.
Kazantseva L; Becerra J; Santos-Ruiz L
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956961
[TBL] [Abstract][Full Text] [Related]
12. Synergy between sublethal doses of shikonin and metformin fully inhibits breast cancer cell migration and reverses epithelial-mesenchymal transition.
Tabari AR; Gavidel P; Sabouni F; Gardaneh M
Mol Biol Rep; 2022 Jun; 49(6):4307-4319. PubMed ID: 35525887
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment.
Wang Q; Wang J; Wang J; Ju X; Zhang H
Toxicol Res (Camb); 2021 Dec; 10(6):1077-1084. PubMed ID: 34956612
[TBL] [Abstract][Full Text] [Related]
14. Shikonin Induced Program Cell Death through Generation of Reactive Oxygen Species in Renal Cancer Cells.
Tsai MF; Chen SM; Ong AZ; Chung YH; Chen PN; Hsieh YH; Kang YT; Hsu LS
Antioxidants (Basel); 2021 Nov; 10(11):. PubMed ID: 34829701
[TBL] [Abstract][Full Text] [Related]
15. Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies.
Hernández ÁP; Juanes-Velasco P; Landeira-Viñuela A; Bareke H; Montalvillo E; Góngora R; Fuentes M
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34198850
[TBL] [Abstract][Full Text] [Related]
16. Naringenin inhibits migration, invasion, induces apoptosis in human lung cancer cells and arrests tumour progression in vitro.
Shi X; Luo X; Chen T; Guo W; Liang C; Tang S; Mo J
J Cell Mol Med; 2021 Mar; 25(5):2563-2571. PubMed ID: 33523599
[TBL] [Abstract][Full Text] [Related]
17. Alkannin-Induced Oxidative DNA Damage Synergizes With PARP Inhibition to Cause Cancer-Specific Cytotoxicity.
Chang M; Wang H; Niu J; Song Y; Zou Z
Front Pharmacol; 2020; 11():610205. PubMed ID: 33519476
[No Abstract] [Full Text] [Related]
18. Shikonin enhances the antitumor effect of cabazitaxel in prostate cancer stem cells and reverses cabazitaxel resistance by inhibiting ABCG2 and ALDH3A1.
Wang L; Stadlbauer B; Lyu C; Buchner A; Pohla H
Am J Cancer Res; 2020; 10(11):3784-3800. PubMed ID: 33294267
[TBL] [Abstract][Full Text] [Related]
19. Zeaxanthin Induces Apoptosis via ROS-Regulated MAPK and AKT Signaling Pathway in Human Gastric Cancer Cells.
Sheng YN; Luo YH; Liu SB; Xu WT; Zhang Y; Zhang T; Xue H; Zuo WB; Li YN; Wang CY; Jin CH
Onco Targets Ther; 2020; 13():10995-11006. PubMed ID: 33149614
[TBL] [Abstract][Full Text] [Related]
20. Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction.
Wang F; Mayca Pozo F; Tian D; Geng X; Yao X; Zhang Y; Tang J
Front Pharmacol; 2020; 11():861. PubMed ID: 32581812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
